Promising results shown for kidney cancer drug
Monday, February 8, 2010 - 01:14
in Health & Medicine
The drug pazopanib (Votrient) slowed the progression of advanced renal cell carcinoma, a form of kidney cancer, in patients by 54 percent, according to a new study.